Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleGastrointestinal, Hepatic, Pulmonary, and Renal

M1 Polarization bias and subsequent NASH progression is attenuated by nitric oxide donor DETA NONOate via inhibition of CYP2E1 induced oxidative stress in obese mice

Ratanesh Kumar Seth, Suvarthi Das, Sahar Pourhosseini, Diptadip Dattaroy, Stephen Igwe, Julie Basuray, Daping Fan, Gregory A Michelotti, Anna Mae Diehl and SAURABH CHATTERJEE
Journal of Pharmacology and Experimental Therapeutics October 27, 2014, jpet.114.218131; DOI: https://doi.org/10.1124/jpet.114.218131
Ratanesh Kumar Seth
1 University of South Carolina;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Suvarthi Das
1 University of South Carolina;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sahar Pourhosseini
1 University of South Carolina;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Diptadip Dattaroy
1 University of South Carolina;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen Igwe
2 Dillard University;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julie Basuray
2 Dillard University;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daping Fan
1 University of South Carolina;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gregory A Michelotti
3 Duke University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Mae Diehl
3 Duke University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SAURABH CHATTERJEE
1 University of South Carolina;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Abstract

Activation of M1 macrophages in the nonalcoholic steatohepatitis (NASH) following several external or endogenous factors viz inflammatory stimuli, oxidative stress and cytokines are known. However, any direct role of oxidative stress in causing M1 polarization in NASH has been unclear. We hypothesized that CYP2E1-mediated oxidative stress causes M1 polarization in experimental NASH and NO donor administration inhibits CYP2E1 mediated inflammation with concomitant attenuation of M1 polarization. Since CYP2E1 takes center stage in these studies we use a toxin model of NASH which uses a ligand and a substrate of CYP2E1 for inducing NASH. Subsequently we use a methionine and choline deficient diet induced rodent NASH model where CYP2E1 role in disease progression has been shown. Results show that CYP2E1 causes M1 polarization bias that includes a significant increase in IL-1β and IL-12 in both models of NASH while CYP2E1 null mice or diallyl sulfide administration prevented it. Administration of GdCl3, a macrophage toxin attenuated both the initial M1 response and subsequent M2 response showing the observed increase in cytokine levels is primarily from macrophages. Based on the evidence of an adaptive NO increase, NO donor administration in vivo, that mechanistically inhibited CYP2E1 catalyzed oxidative stress during the entire study in NASH abrogated M1 polarization and NASH progression. The results obtained show the association of CYP2E1 in M1 polarization and that inhibition of CYP2E1 catalyzed oxidative stress by NO donor (DETA NONOate) can be a promising therapeutic strategy in NASH.

  • CYP2E1
  • hepatotoxicity
  • Kupffer cells
  • liver disease
  • oxidative stress
  • The American Society for Pharmacology and Experimental Therapeutics
Next
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 385 (1)
Journal of Pharmacology and Experimental Therapeutics
Vol. 385, Issue 1
1 Apr 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
M1 Polarization bias and subsequent NASH progression is attenuated by nitric oxide donor DETA NONOate via inhibition of CYP2E1 induced oxidative stress in obese mice
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleGastrointestinal, Hepatic, Pulmonary, and Renal

M1 Polarization bias and subsequent NASH progression is attenuated by nitric oxide donor DETA NONOate via inhibition of CYP2E1 induced oxidative stress in obese mice

Ratanesh Kumar Seth, Suvarthi Das, Sahar Pourhosseini, Diptadip Dattaroy, Stephen Igwe, Julie Basuray, Daping Fan, Gregory A Michelotti, Anna Mae Diehl and SAURABH CHATTERJEE
Journal of Pharmacology and Experimental Therapeutics October 27, 2014, jpet.114.218131; DOI: https://doi.org/10.1124/jpet.114.218131

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleGastrointestinal, Hepatic, Pulmonary, and Renal

M1 Polarization bias and subsequent NASH progression is attenuated by nitric oxide donor DETA NONOate via inhibition of CYP2E1 induced oxidative stress in obese mice

Ratanesh Kumar Seth, Suvarthi Das, Sahar Pourhosseini, Diptadip Dattaroy, Stephen Igwe, Julie Basuray, Daping Fan, Gregory A Michelotti, Anna Mae Diehl and SAURABH CHATTERJEE
Journal of Pharmacology and Experimental Therapeutics October 27, 2014, jpet.114.218131; DOI: https://doi.org/10.1124/jpet.114.218131
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • MIP3α in Progressive Renal Injury Associated with Obesity
  • A Novel Long-Acting GLP-2, HM15912, for Short Bowel Syndrome
  • H2S Overproduction and Colonic Hypomotility in DM
Show more Gastrointestinal, Hepatic, Pulmonary, and Renal

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics